Mike Hollan is an assistant managing editor for Medical Device and Technology and Pharmaceutical Executive, and he can be reached at mhollan@mjhlifesciences.com.
Trial Launches to Explore Using Virtual Reality to Treat Shortsightedness in Children
July 27th 2023A new trial will determine the effectiveness of using virtual reality to treat myopia in children. The treatment combines the use of a VR headset with a phone app that is designed to stimulate dopamine releases in the retina.
Q&A With Hansa Bhargava, MD, Chief Medical Officer at Medscape Education
June 15th 2023At the DTX Summit held in Washington DC on June 6-9, 2023, Dr. Hansa Bhargava participated in a panel discussion about putting the patient and provider first in the field of digital therapeutics. After the event, she sat with MD&T to further discuss how education around new therapies is impacting patients and providers.